Status:
COMPLETED
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
Lead Sponsor:
Pfizer
Conditions:
Psoriasis
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a phase 4, multicenter, randomized, non-therapeutic interventional trial in subjects with psoriasis looking for the prevalence of psoriatic arthritis. Subjects will be seen and evaluated by a ...
Eligibility Criteria
Inclusion
- Subject is \>18 years of age at the time of consent.
- Subject has a confirmed diagnosis of plaque psoriasis by clinical judgment.
- Subject is able to read and complete questionnaires.
- Subjects planning to undergo radiographic evaluation, should not have any contraindications to MRI.
Exclusion
- None.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
1013 Patients enrolled
Trial Details
Trial ID
NCT01147874
Start Date
August 1 2010
End Date
July 1 2011
Last Update
June 21 2012
Active Locations (45)
Enter a location and click search to find clinical trials sorted by distance.
1
Modern Research Assoc. PLLC
Dallas, Texas, United States, 75205
2
Rheumatology Practive of Scott Zashin, MD
Dallas, Texas, United States, 75231
3
Center for Clinical Studies Ltd LLP
Houston, Texas, United States, 77030
4
Rheumatology Associates of Houston
Houston, Texas, United States, 77054